Dr. Suman Kambhampati
Claim this profileResearch Medical Center
Studies Lymphoma
Studies Leukemia
16 reported clinical trials
33 drugs studied
Area of expertise
1Lymphoma
Stage I
Stage II
Stage III
2Leukemia
BCR-ABL1 positive
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Suman Kambhampati is currently running
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting2 awards Phase 310 criteria
Iberdomide + Daratumumab vs. Bortezomib
for Multiple Myeloma
This is a multicenter, two-stage, randomized, controlled, open-label, Phase 3 study comparing the efficacy and safety of iberdomide in combination with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple myeloma (RRMM).
Recruiting2 awards Phase 3
More about Suman Kambhampati
Clinical Trial Related5 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Suman Kambhampati has experience with
- Venetoclax
- Dexamethasone
- Azacitidine
- Lenalidomide
- Bortezomib
- Rituximab
Breakdown of trials Suman Kambhampati has run
Lymphoma
Leukemia
Multiple Myeloma
Plasma Cell Neoplasms
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Suman Kambhampati specialize in?
Suman Kambhampati focuses on Lymphoma and Leukemia. In particular, much of their work with Lymphoma has involved Stage I patients, or patients who are Stage II.
Is Suman Kambhampati currently recruiting for clinical trials?
Yes, Suman Kambhampati is currently recruiting for 6 clinical trials in Kansas City Missouri. If you're interested in participating, you should apply.
Are there any treatments that Suman Kambhampati has studied deeply?
Yes, Suman Kambhampati has studied treatments such as Venetoclax, Dexamethasone, Azacitidine.
What is the best way to schedule an appointment with Suman Kambhampati?
Apply for one of the trials that Suman Kambhampati is conducting.
What is the office address of Suman Kambhampati?
The office of Suman Kambhampati is located at: Research Medical Center, Kansas City, Missouri 64132 United States. This is the address for their practice at the Research Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.